India's Strides Pharma Science gains on US FDA nod for seizure drug

Strides Pharma Science

21/11/2023 06:26

** Shares of Strides Pharma Science  SRID.NS  rise as much
as 3.84% to 509.40 rupees apiece
    ** Rise after drugmaker's unit receives approval from U.S.
FDA for drug used to treat seizures, called Levetiracetam Oral
solution
    ** Drug has a market size of $55 million, according to
analytics firm IQVIA
    ** Drug to be made in SRID's Bengaluru facility
    ** Trading volume is 504,528 shares as of 11:44 a.m. IST,
1.3x the 30-day avg - LSEG data
    ** SRID shares up 43% YTD, including today's gains, compared
to 26.4% rise in pharma index  .NIPHARM 

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))